Literature DB >> 27161602

Laboratory testing for antiphospholipid syndrome.

V Pengo1, A Banzato1, E Bison1, G Denas1, G Zoppellaro1, A Bracco1, S Padayattil Jose1, A Hoxha2, A Ruffatti2.   

Abstract

This is a practical report on laboratory tests for the diagnosis of antiphospholipid syndrome (APS). After a general definition of APS, this study deals with appropriateness and timing in requesting the determination of antiphospholipid (aPL) antibodies. Lupus anticoagulant (LAC), anticardiolipin (aCL), and anti β2-glycoprotein I (aβGPI) are the mandatory tests to be performed, while other tests are not yet validated for clinical use. Interpretation of results is an important discussed issue that implies a close liaison between clinical pathologists and clinicians. Finally, a personal definition of APS according to aPL antibody profile closes the manuscript.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Phospholipid; laboratory; syndrome; testing

Mesh:

Substances:

Year:  2016        PMID: 27161602     DOI: 10.1111/ijlh.12507

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  3 in total

1.  Discovery and characterization of 2 novel subpopulations of aPS/PT antibodies in patients at high risk of thrombosis.

Authors:  Mathivanan Chinnaraj; William Planer; Vittorio Pengo; Nicola Pozzi
Journal:  Blood Adv       Date:  2019-06-11

2.  Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome.

Authors:  Chun-Yu Lin; Chun-Ching Chiu; Ju Cheng; Chia-Yun Lin; Ya-Fang Shi; Chun-Chou Tsai; Bor-Show Tzang; Tsai-Ching Hsu
Journal:  Virulence       Date:  2017-11-30       Impact factor: 5.882

3.  Antiprothrombin antibodies induce platelet activation: A possible explanation for anti-FXa therapy failure in patients with antiphospholipid syndrome?

Authors:  Walid Chayoua; Phillip L R Nicolson; Joost C M Meijers; Caroline Kardeby; Lourdes Garcia-Quintanilla; Katrien M J Devreese; Bas de Laat; Stephen P Watson; Philip G de Groot
Journal:  J Thromb Haemost       Date:  2021-05-05       Impact factor: 5.824

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.